LABCORP HOLDINGS INC (LH)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for LH
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LH | [] | [] | 2026 |
Biography sourced from the proxy statement filing.
John H. Sampson has served as a director of the Company and member of the Quality and Compliance Committee since February 2026. Dr. Sampson is a practicing neurosurgeon and the Richard D. Krugman Endowed Chair, Vice Chancellor for Health Affairs, Dean of the University of Colorado Anschutz School of Medicine, and President of CU Medicine. Prior to serving at the University of Colorado, he was Senior Vice President in the Duke University Health System and led the Duke Health Integrated Practice. Dr. Sampson holds a Bachelor of Science degree and a Doctor of Medicine from the University of Manitoba, a Master of Health Science in clinical research from Duke University, as well as Master of Business Administration from Duke University s Fuqua School of Business. Skills and Qualifications: Extensive experience in the healthcare industry Scientific expertise in oncology, neuroscience, and immunology Expertise in supervising cybersecurity matters Committees: Quality and Compliance Committee Previous Public Company Board Experience: Medicenna Therapeutics Corp. Other Current Relevant Experience: Member of the American Society for Clinical Investigation (ASCI) Member of the Association of American Physicians (AAP) Member of the National Academy of Medicine (NAM) Business Strategy Executive Leadership Healthcare/ Clinical Research Risk Management Talent Management Technology/ Cybersecurity